A phase I--II design based on periodic and continuous monitoring of disease status and the times to toxicity and death (Q6627403)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A phase I--II design based on periodic and continuous monitoring of disease status and the times to toxicity and death |
scientific article; zbMATH DE number 7934173
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I--II design based on periodic and continuous monitoring of disease status and the times to toxicity and death |
scientific article; zbMATH DE number 7934173 |
Statements
A phase I--II design based on periodic and continuous monitoring of disease status and the times to toxicity and death (English)
0 references
29 October 2024
0 references
adaptive randomization
0 references
Bayesian design
0 references
dose finding
0 references
interim response
0 references
mixed hazard
0 references
phase I--II clinical trial
0 references
0 references
0 references
0 references
